The combination of Henry Schein’s distribution capabilities with Acentus’ technology expertise will pack a one-two punch as ...
The stock's rise snapped a three-day losing streak.
Equities research analysts at William Blair lowered their Q1 2025 earnings per share (EPS) estimates for shares of Henry Schein in a research note issued to investors on Tuesday, March 11th. William ...
Shares of Henry Schein Inc. HSIC slipped 4.09% to $69.94 Wednesday, on what proved to be an all-around mixed trading session ...
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical ...
Investor's Business Daily on MSN4d
Henry Schein Shows Improved Relative Strength; Still Shy Of BenchmarkRating, from 69 to 74. Please watch the video at Investors.com - How To Find The Best IPO Stocks IBD's unique rating tracks ...
Henry Schein has been outperforming the S&P 500 since December 2024. Check out the price action, momentum, volume, and ...
Dental and medical products company Henry Schein (NASDAQ:HSIC) in Q4 CY2024, but sales rose 5.8% year on year to $3.19 billion. Its non-GAAP profit of $1.19 per share was 1.6% below analysts’ ...
Henry Schein's market leadership and strategic acquisitions across various healthcare segments make it a solid investment, ...
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today repor ...
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
Henry Schein is supporting the Special Olympics Healthy Athletes screenings at the Special Olympics World Winter Games March 8-15, 2025, in Turin, Italy, by donating a range of oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback